Eliminate Clinical Data Errors Before They Trigger GCP Audits and Regulatory Delays

Manual Clinical Data Management Is a GCP Compliance Liability Waiting to Be Triggered

South African pharmaceutical companies conducting or managing clinical trials operate under SAHPRA's clinical trial regulations, ICH E6 GCP guidelines, and increasingly stringent international standards as SA sites participate in multi-regional trials. Manual data management in this environment creates systematic risk of data integrity failures, protocol deviations, and audit findings that can invalidate data and delay regulatory submissions by years.

• Clinical data collected across multiple South African sites - in Johannesburg, Cape Town, Durban, and Pretoria - is typically consolidated manually from EDC exports, paper CRFs, and lab system downloads, creating version control and reconciliation risk
• Protocol deviation tracking is done in Excel, with no automated detection of out-of-range values, missed visits, or prohibited concomitant medications - deviations are discovered during CRA monitoring visits rather than in real time
• Data lock procedures that should take 2-3 weeks take 6-8 weeks due to manual query generation, investigator response tracking, and multi-system reconciliation processes
• SAE (serious adverse event) detection and reporting to SAHPRA within the required 7-15 day window is managed through manual review processes that create compliance risk
• Statistical analysis datasets require extensive manual curation and CDISC SDTM mapping before submission - a process that adds 8-16 weeks to every regulatory dossier preparation cycle

How It Works

Frequently Asked Questions